GOLDMAN CAPITAL MANAGEMENT INC - Q2 2014 holdings

$201 Million is the total value of GOLDMAN CAPITAL MANAGEMENT INC's 33 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 19.4% .

 Value Shares↓ Weighting
IWSY  Imageware Systems Inc.$77,774,000
+21.0%
34,566,2100.0%38.60%
+10.9%
HILL SellDot Hill Sys Corp$21,025,000
+12.9%
4,473,317
-0.8%
10.44%
+3.5%
MDCA BuyMdc Partners Inc New Cl A Subo$10,201,000
+4.6%
474,700
+18.9%
5.06%
-4.1%
PCYG SellPark City Group Inc.$9,385,000
-19.7%
861,800
-25.4%
4.66%
-26.3%
REFR BuyResearch Frontiers Inc$9,177,000
+46.1%
1,514,438
+9.7%
4.56%
+33.9%
PHMD SellPhotomedex Inc$7,686,000
-18.9%
627,433
-3.0%
3.82%
-25.6%
TRIB  Trinity Biotech$7,017,000
-6.0%
304,6900.0%3.48%
-13.9%
WLBAQ SellWestmoreland Coal Corp$6,541,000
+5.6%
180,300
-13.9%
3.25%
-3.2%
MATR BuyMattersight Corp$6,485,000
+2.6%
1,221,356
+22.0%
3.22%
-5.9%
LOCM  Local.com Corp$6,299,000
+11.9%
3,035,7000.0%3.13%
+2.6%
LCUT BuyLifetime Brands Inc$6,204,000
-15.8%
394,657
+2.3%
3.08%
-22.8%
MOSY BuyMosys Inc$5,015,000
+9.4%
1,597,046
+36.2%
2.49%
+0.3%
ICGE SellIcg Group Inc$4,399,000
+2.3%
210,700
-0.1%
2.18%
-6.2%
RCPI NewRock Creek Pharmaceuticals Inc$3,304,0005,600,600
+100.0%
1.64%
CTHR BuyCharles & Colvard Ltd$3,073,000
+2.2%
1,396,900
+0.8%
1.52%
-6.3%
DPDW BuyDeep Down Inc$2,499,000
+3.3%
1,351,000
+13.9%
1.24%
-5.3%
CYTX BuyCytori Therapeutics Inc$2,395,000
+181.4%
1,022,288
+171.6%
1.19%
+157.9%
CXDO BuyCrexendo Inc.$2,392,000
+6.9%
747,569
+5.6%
1.19%
-2.1%
CYRN SellCyren Ltd$2,088,000
-4.1%
725,000
-1.1%
1.04%
-12.1%
OPRX BuyOptimirex Corp$1,738,000
+13.7%
1,093,334
+15.9%
0.86%
+4.4%
BONE BuyBacterin Intl Holdings Inc$1,411,000
+44.3%
2,090,000
+48.8%
0.70%
+32.3%
IZEA  Izea Inc$1,279,000
-15.5%
2,857,1440.0%0.64%
-22.6%
HPTO BuyHopto Inc$808,000
-40.0%
6,733,333
+499.4%
0.40%
-45.0%
WAVX NewWave Systems Corp$636,000451,000
+100.0%
0.32%
QTM NewQuantum Corp$610,000500,000
+100.0%
0.30%
III SellInformation Services Group Inc.$483,000
-9.2%
100,400
-6.6%
0.24%
-16.7%
NNTCF BuyNanotech Securities Corp$479,000
+22.5%
300,000
+9.8%
0.24%
+12.3%
MLSS NewMilestone Scientific Inc$380,000200,000
+100.0%
0.19%
SMED BuySharps Compliance Corp$228,000
+178.0%
51,873
+159.4%
0.11%
+156.8%
SLTC  Selectica Inc$215,000
+8.6%
33,3330.0%0.11%0.0%
ERI BuyEmrise Corp$88,000
+46.7%
100,000
+49.2%
0.04%
+37.5%
PFSW SellPfsweb Inc$83,000
-81.2%
10,000
-81.8%
0.04%
-82.8%
BuyPivotal Therapeutics Inc.$81,000
-51.2%
1,000,000
+2.7%
0.04%
-55.6%
AMPE ExitAmpio Pharmaceuticals Inc$0-210,000
-100.0%
-0.69%
STSI ExitStar Scientific Inc Com$0-5,423,600
-100.0%
-1.93%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2014-10-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Imageware Systems Inc. (IWSY)19Q4 201754.4%
Icg Group Inc19Q4 201711.0%
Park City Group Inc. (PCYG)19Q4 20177.3%
MDC Partners Inc New Cl A Subo (MDCA)19Q4 20177.7%
Mattersight Corp (MATR)19Q4 20177.9%
Research Frontiers Inc (REFR)19Q4 20177.1%
Trinity Biotech (TRIB)19Q4 20174.5%
Charles & Colvard Ltd (CTHR)19Q4 201711.2%
Deep Down Inc (DPDW)19Q4 20171.4%
Crexendo Inc.(CXDO)18Q3 20171.2%

View GOLDMAN CAPITAL MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)
GOLDMAN CAPITAL MANAGEMENT INC Q2 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CYREN Ltd.February 22, 20162,092,1315.3%
Crexendo, Inc.February 17, 2015753,0546.7%
DOT HILL SYSTEMS CORPFebruary 17, 20154,093,3176.8%
PHOTOMEDEX INCJanuary 07, 20151,050,0995.5%
OptimizeRx CorpOctober 24, 20141,532,3946.5%
CHARLES & COLVARD LTDApril 03, 20141,344,4946.7%
Bacterin International Holdings, Inc.December 12, 20131,500,0002.9%
LOCAL CorpSeptember 26, 20131230.0%
RESEARCH FRONTIERS INCSeptember 26, 20131,179,0005.1%
TRINITY BIOTECH PLCJanuary 28, 2013622,0002.9%

View GOLDMAN CAPITAL MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2018-02-14
13F-HR2017-11-09
13F-HR2017-08-14
13F-HR2017-05-09
13F-HR2017-01-19
13F-HR2016-10-31
13F-HR2016-07-29
13F-HR2016-05-13
SC 13G2016-02-22
13F-HR2016-02-16

View GOLDMAN CAPITAL MANAGEMENT INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export GOLDMAN CAPITAL MANAGEMENT INC's holdings